BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11844681)

  • 1. Synthesis of 5,6-dihydro-11H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidine-N-cyanoguanidine derivatives as inhibitors of ras farnesyl protein transferase.
    Cooper AB; Strickland CL; Wang J; Desai J; Kirschmeier P; Patton R; Bishop WR; Weber PC; Girijavallabhan V
    Bioorg Med Chem Lett; 2002 Feb; 12(4):601-5. PubMed ID: 11844681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumor compounds.
    Njoroge FG; Vibulbhan B; Rane DF; Bishop WR; Petrin J; Patton R; Bryant MS; Chen KJ; Nomeir AA; Lin CC; Liu M; King I; Chen J; Lee S; Yaremko B; Dell J; Lipari P; Malkowski M; Li Z; Catino J; Doll RJ; Girijavallabhan V; Ganguly AK
    J Med Chem; 1997 Dec; 40(26):4290-301. PubMed ID: 9435898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of farnesyl protein transferase. Synthesis and biological activity of amide and cyanoguanidine derivatives containing a 5,11-dihydro[1]benzthiepin, benzoxepin, and benzazepin [4,3-b]pyridine ring system.
    Wolin R; Connolly M; Kelly J; Weinstein J; Rosenblum S; Afonso A; James L; Kirschmeier P; Bishop WR
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2521-6. PubMed ID: 9873573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogs of 4-(3-bromo-8-methyl-10-methoxy-6,11-dihydro-5H-benzo[5,6]-cyclo hepta[1,2-b]pyridin-11-yl)-1-(4-pyridinylacetyl)piperidine N-oxide as inhibitors of farnesyl protein transferase.
    Afonso A; Kelly J; Weinstein J; James L; Bishop WR
    Bioorg Med Chem Lett; 1999 Jul; 9(13):1875-80. PubMed ID: 10406658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analogues of 1-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo-[5,6]-cyclohepta [1,2-b]pyridin-11-yl)piperidine as inhibitors of farnesyl protein transferase.
    Afonso A; Weinstein J; Kelly J; Wolin R; Rosenblum SB; Connolly M; Guzi T; James L; Carr D; Patton R; Bishop WR; Kirshmeier P; Liu M; Heimark L; Chen KJ; Nomeir AA
    Bioorg Med Chem; 1999 Sep; 7(9):1845-55. PubMed ID: 10530932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic farnesyl protein transferase inhibitors: crystallographic and calorimetric studies of structure-activity relationships.
    Strickland CL; Weber PC; Windsor WT; Wu Z; Le HV; Albanese MM; Alvarez CS; Cesarz D; del Rosario J; Deskus J; Mallams AK; Njoroge FG; Piwinski JJ; Remiszewski S; Rossman RR; Taveras AG; Vibulbhan B; Doll RJ; Girijavallabhan VM; Ganguly AK
    J Med Chem; 1999 Jun; 42(12):2125-35. PubMed ID: 10377218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine.
    Mallams AK; Rossman RR; Doll RJ; Girijavallabhan VM; Ganguly AK; Petrin J; Wang L; Patton R; Bishop WR; Carr DM; Kirschmeier P; Catino JJ; Bryant MS; Chen KJ; Korfmacher WA; Nardo C; Wang S; Nomeir AA; Lin CC; Li Z; Chen J; Lee S; Dell J; Lipari P; Liu M
    J Med Chem; 1998 Mar; 41(6):877-93. PubMed ID: 9526562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel farnesyl protein transferase inhibitors using three-dimensional database searching methods.
    Kaminski JJ; Rane DF; Snow ME; Weber L; Rothofsky ML; Anderson SD; Lin SL
    J Med Chem; 1997 Dec; 40(25):4103-12. PubMed ID: 9406600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of isomeric 3-piperidinyl and 3-pyrrolidinyl benzo[5,6]cyclohepta[1,2-b]pyridines: sulfonamido derivatives as inhibitors of Ras prenylation.
    Kelly J; Wolin R; Connolly M; Afonso A; James L; Kirshmeier P; Bishop WR; McPhail AT
    Bioorg Med Chem; 1998 Jun; 6(6):673-86. PubMed ID: 9681133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (+)-4-[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5, 6]cyclohepta[1,2-b]- pyridin-11(R)-yl)-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamid e (SCH-66336): a very potent farnesyl protein transferase inhibitor as a novel antitumor agent.
    Njoroge FG; Taveras AG; Kelly J; Remiszewski S; Mallams AK; Wolin R; Afonso A; Cooper AB; Rane DF; Liu YT; Wong J; Vibulbhan B; Pinto P; Deskus J; Alvarez CS; del Rosario J; Connolly M; Wang J; Desai J; Rossman RR; Bishop WR; Patton R; Wang L; Kirschmeier P; Ganguly AK
    J Med Chem; 1998 Nov; 41(24):4890-902. PubMed ID: 9822558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the role of bromine at C(10) of (+)-4-[2-[4-(8-chloro-3,10-dibromo- 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11(R)-yl)-1-piperidinyl]-2- oxoethyl]-1-piperidinecarboxamide (Sch-66336): the discovery of indolocycloheptapyridine inhibitors of farnesyl protein transferase.
    Taveras AG; Aki C; Chao J; Doll RJ; Lalwani T; Girijavallabhan V; Strickland CL; Windsor WT; Weber P; Hollinger F; Snow M; Patton R; Kirschmeier P; James L; Liu M; Nomeir A
    J Med Chem; 2002 Aug; 45(18):3854-64. PubMed ID: 12190309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
    Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
    Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
    Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
    J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trihalobenzocycloheptapyridine analogues of Sch 66336 as potent inhibitors of farnesyl protein transferase.
    Njoroge FG; Vibulbhan B; Pinto P; Strickland CL; Bishop WR; Kirschmeir P; Girijavallabhan V; Ganguly AK
    Bioorg Med Chem; 2003 Jan; 11(1):139-43. PubMed ID: 12467716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of pharmacokinetically stable 3, 10-dibromo-8-chlorobenzocycloheptapyridine farnesyl protein transferase inhibitors with potent enzyme and cellular activities.
    Taveras AG; Deskus J; Chao J; Vaccaro CJ; Njoroge FG; Vibulbhan B; Pinto P; Remiszewski S; del Rosario J; Doll RJ; Alvarez C; Lalwani T; Mallams AK; Rossman RR; Afonso A; Girijavallabhan VM; Ganguly AK; Pramanik B; Heimark L; Bishop WR; Wang L; Kirschmeier P; James L; Carr D; Liu M
    J Med Chem; 1999 Jul; 42(14):2651-61. PubMed ID: 10411485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a human carcinoma cell line selected for resistance to the farnesyl transferase inhibitor 4-(2-(4-(8-chloro-3,10-dibromo-6,11-dihydro-5H-benzo-(5,6)-cyclohepta(1,2-b)-pyridin-11(R)-yl)-1-piperidinyl)-2-oxo-ethyl)-1-piperidinecarboxamide (SCH66336).
    Bruzek LM; Poynter JN; Kaufmann SH; Adjei AA
    Mol Pharmacol; 2005 Aug; 68(2):477-86. PubMed ID: 15901852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic kinetic resolution of piperidine atropisomers: synthesis of a key intermediate of the farnesyl protein transferase inhibitor, SCH66336.
    Morgan B; Zaks A; Dodds DR; Liu J; Jain R; Megati S; Njoroge FG; Girijavallabhan VM
    J Org Chem; 2000 Sep; 65(18):5451-9. PubMed ID: 10970281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and Evaluation of Novel 1-(Substituted Acetyl)-4-(10-Bromo-8-Chloro-5,6-Dihydro-11H-Benzo[5,6]Cyclohepta[1,2-B]Pyridine-11-Ylidene)piperidines as Antitumor Agents and Farnesyl Protein Transferase Inhibitors.
    Gatne PS; Viswanathan CL; Ambre PK; Juvekar A
    Indian J Pharm Sci; 2010 Sep; 72(5):663-7. PubMed ID: 21695007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases.
    Tucker TJ; Abrams MT; Buser CA; Davide JP; Ellis-Hutchings M; Fernandes C; Gibbs JB; Graham SL; Hartman GD; Huber HE; Liu D; Lobell RB; Lumma WC; Robinson RG; Sisko JT; Smith AM
    Bioorg Med Chem Lett; 2002 Aug; 12(15):2027-30. PubMed ID: 12113834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel nonpeptide tricyclic inhibitors of Ras farnesyl protein transferase.
    Njoroge FG; Doll RJ; Vibulbhan B; Alvarez CS; Bishop WR; Petrin J; Kirschmeier P; Carruthers NI; Wong JK; Albanese MM; Piwinski JJ; Catino J; Girijavallabhan V; Ganguly AK
    Bioorg Med Chem; 1997 Jan; 5(1):101-13. PubMed ID: 9043662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.